At ReproNovo, we are redefining what's possible in reproductive medicine and women's health. We are advancing innovative therapeutic solutions for both male and female infertility, as well as pioneering treatment options for uterine conditions like adenomyosis, delivering meaningful change to patients worldwide. Our international team brings together deep expertise across reproductive medicine, drug development, regulatory strategy, and business developmentwith a proven track record of bringing multiple therapies to market.
02.10.2025
Life sciences companies make positive progress (startupticker.ch)
23.07.2025
Three biotechs on the verge of launching potential treatments (startupticker.ch)
21.05.2025
ReproNovo raises USD65 million to advance Phase II clinical trials (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Website:
repronovo.com
Headquarter:
Lausanne
Foundation Date:
October 2021
Technology: